Author: Xu, Lin; Tan, Bo; Huang, Di; Yuan, Meijie; Li, Tingting; Wu, Ming; Ye, Chaoyang
Title: Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys Cord-id: kbd7jbcg Document date: 2021_7_2
ID: kbd7jbcg
Snippet: Aim: Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms. Methods: Remdesivir and its active nucleoside metabolite GS-441524 were used to treat TGF-β stimulated renal fibroblasts (NRK-49F) and human renal epithelial (HK2) cells. Vehicle or remdesivir were given by intraperitoneal injection or renal injection through the
Document: Aim: Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms. Methods: Remdesivir and its active nucleoside metabolite GS-441524 were used to treat TGF-β stimulated renal fibroblasts (NRK-49F) and human renal epithelial (HK2) cells. Vehicle or remdesivir were given by intraperitoneal injection or renal injection through the left ureter in unilateral ureteral obstruction (UUO) mice. Serum and kidneys were harvested. The concentrations of remdesivir and GS-441524 were measured using LC-MS/MS. Renal and liver function were assessed. Renal fibrosis was evaluated by Masson’s trichrome staining and Western blotting. Results: Remdesivir and GS-441524 inhibited the expression of fibrotic markers (fibronectin and aSMA) in NRK-49F and HK2 cells. Intraperitoneal injection or renal injection of remdesivir attenuated renal fibrosis in UUO kidneys. Renal and liver function were unchanged in remdesivir treated UUO mice. Two remdesivir metabolites were detected after injection. Phosphorylation of Smad3 that was enhanced in cell and animal models for renal fibrosis was attenuated by remdesivir. In addition, the expression of Smad7, an anti-fibrotic factor, was increased after remdesivir treatment in vitro and in vivo. Moreover, knockdown of Smad7 blocked the antifibrotic effect of GS and RDV on renal cells. Conclusion: Remdesivir inhibits renal fibrosis in obstructed kidneys.
Search related documents:
Co phrase search for related documents- acid complex and active metabolite: 1
- acid complex and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
- active metabolite and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- active metabolite and liver function: 1, 2
- active metabolite and liver renal: 1, 2
- active metabolite and liver renal function: 1
- active metabolite gs and acute sars respiratory syndrome coronavirus: 1
- active metabolite gs and liver function: 1
- active metabolite gs and liver renal: 1
- active metabolite gs and liver renal function: 1
- active triphosphate metabolite and acute sars respiratory syndrome coronavirus: 1, 2, 3
- acute renal failure and liver function: 1, 2
- acute renal failure and liver renal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute renal failure and liver renal function: 1, 2
- acute sars respiratory syndrome coronavirus and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars respiratory syndrome coronavirus and liver renal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute sars respiratory syndrome coronavirus and liver renal function: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date